These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35134140)

  • 1. Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD].
    Narula N; Pray C; Wong ECL; Colombel JF; Marshall JK; Daperno M; Reinisch W; Dulai PS
    J Crohns Colitis; 2022 Aug; 16(7):1011-1019. PubMed ID: 35134140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.
    Narula N; Wong ECL; Colombel JF; Sandborn WJ; Ferrante M; Marshall JK; Reinisch W; Dulai PS
    J Crohns Colitis; 2022 May; 16(4):616-624. PubMed ID: 34664635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD).
    Narula N; Wong ECL; Colombel JF; Sandborn WJ; Marshall JK; Daperno M; Reinisch W; Dulai PS
    Gut; 2022 Jun; 71(6):1078-1087. PubMed ID: 33766910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
    Narula N; Wong ECL; Aruljothy A; Dulai PS; Colombel JF; Marshall JK; Ferrante M; Reinisch W
    J Clin Gastroenterol; 2023 Oct; 57(9):913-919. PubMed ID: 36227009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.
    Pray C; Wong ECL; Aruljothy A; Dulai PS; Marshall JK; Reinisch W; Narula N
    Inflamm Bowel Dis; 2023 Aug; 29(8):1263-1271. PubMed ID: 36179118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.
    Narula N; Wong ECL; Dulai PS; Marshall JK; Jairath V; Reinisch W
    Inflamm Bowel Dis; 2023 May; 29(5):716-725. PubMed ID: 35762666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity.
    Adler J; Colletti RB; Noonan L; Berzin TM; Cheifetz AS; Conklin LS; Hoops TC; Huang CS; Lewis B; Mishkin DS; Hung Lo K; Xiao Y; Volger S
    Inflamm Bowel Dis; 2023 Jul; 29(7):1089-1097. PubMed ID: 36049024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
    Narula N; Wong ECL; Dulai PS; Patel J; Marshall JK; Yzet C; Jairath V; Ungaro R; Colombel JF; Reinisch W;
    Clin Gastroenterol Hepatol; 2024 Aug; 22(8):1687-1696.e6. PubMed ID: 38428709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease.
    Wong ECL; Buffone E; Lee SJ; Dulai PS; Marshall JK; Reinisch W; Narula N
    J Crohns Colitis; 2021 Jul; 15(7):1114-1119. PubMed ID: 33245751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis.
    Narula N; Wong ECL; Dulai PS; Marshall JK; Colombel JF; Reinisch W
    J Crohns Colitis; 2021 Oct; 15(10):1649-1657. PubMed ID: 33693522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.
    Sipponen T; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2010 Dec; 16(12):2131-6. PubMed ID: 20848462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the simple endoscopic activity score in crohn's disease.
    Koutroumpakis E; Katsanos KH
    Saudi J Gastroenterol; 2016; 22(3):183-91. PubMed ID: 27184635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Lewis JD; Rutgeerts P; Feagan BG; D'haens G; Danese S; Colombel JF; Reinisch W; Rubin DT; Selinger C; Bewtra M; Barcomb L; Lacerda AP; Wallace K; Butler JW; Wu M; Zhou Q; Liao X; Sandborn WJ
    Inflamm Bowel Dis; 2020 Jan; 26(2):304-313. PubMed ID: 31644790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Khanna R; Zou G; Stitt L; Feagan BG; Sandborn WJ; Rutgeerts P; McDonald JWD; Dubcenco E; Fogel R; Panaccione R; Jairath V; Nelson S; Shackelton LM; Huang B; Zhou Q; Robinson AM; Levesque BG; D'Haens G
    Am J Gastroenterol; 2017 Oct; 112(10):1584-1592. PubMed ID: 28071654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.
    Volkers A; Bossuyt P; de Jong J; Pouillon L; Gecse K; Duijvestein M; Ponsioen C; D'Haens G; Löwenberg M
    Scand J Gastroenterol; 2022 Apr; 57(4):439-445. PubMed ID: 34968158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data.
    Feagan B; Sandborn WJ; Rutgeerts P; Levesque BG; Khanna R; Huang B; Zhou Q; Maa JF; Wallace K; Lacerda A; Thakkar RB; Robinson AM
    Inflamm Bowel Dis; 2018 Apr; 24(5):932-942. PubMed ID: 29668919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Löwenberg M; Vermeire S; Mostafavi N; Hoentjen F; Franchimont D; Bossuyt P; Hindryckx P; Rispens T; de Vries A; van der Woude CJ; Berends S; Ambarus CA; Mathot R; Clasquin E; Baert F; D'Haens G
    Gastroenterology; 2019 Oct; 157(4):997-1006.e6. PubMed ID: 31175865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.